drugset / Trial / NCT01800357

Efficacy and Safety of Mildronate for Acute Ischemic Stroke

NCT01800357

Phase 2 Unknown 240 enrolled Xijing Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study seeks to evaluate the efficacy and safety of mildronate injection in treating acute ischemic stroke

Timeline

Start
2013-01
Primary completion
2014-06
Completion
2014-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Meldonium Small molecule 500 mg
Background Aspirin Small molecule 100 mg

Indications